Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Integer (ITGR). But which of these two companies is the best option for those looking for undervalued stocks?
Integer Holdings' growth momentum has faded, with revenue declining 1.8% year-over-year in 2026Q2, and gross margin contracting 320 basis points from 27.5% in 2024Q2 to 24.3% in 2026Q2, indicating eroding pricing power and potential demand weakness. While cash...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 3, 2026 | $1.60+15.9% vs $1.38 | $464M+2.9% vs $451M |
Q2 2026 Apr 30, 2026 | $1.20-0.8% vs $1.21 | $440M+3.1% vs $426M |
Q1 2026 Feb 19, 2026 | $1.76+3.5% vs $1.70 | $472M+2.0% vs $463M |
Q4 2025 Oct 23, 2025 | $1.79+6.5% vs $1.68 | $468M+1.1% vs $463M |
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Integer (ITGR). But which of these two companies is the best option for those looking for undervalued stocks?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Integer Holdings Corporation (NYSE: ITGR) to KKR for $127.00 per share.Halper Sadeh
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Integer Holdings Corporation (NYSE: ITGR) to KKR for $127.00 per share.Halper Sadeh encourages Integer shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected] investigation concerns whether Integer and its board of directors violated the federal secu.
Benchmark ITGR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Integer Holdings Corporation (ITGR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $126.33 | $4.29B | 43.71 | 7.57% | 5.57% | 6.11% | — | |
| $16.67 | $1.93B | -13.66 | 8.28% | -21.25% | -44% | — | |
| $78.49 | $4.31B | -17.64 | 10.74% | 12.82% | 15.41% | — | |
| $20.89 | $279.57M | -27.49 | -5.91% | -3.14% | -2.7% | — | |
| $10.23 | $100.91M | -3.89 | 15.21% | -13.99% | -20.59% | — | |
| $58.83 | $2.99B | -245.13 | 14.88% | 1.85% | 2.14% | — |
Integer Holdings Corporation (ITGR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Integer Holdings Corporation (ITGR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Aug 3, 2026·SEC
Aug 3, 2026·SEC
Get notified when ITGR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Integer Holdings Corporation (ITGR) stock FAQ — growth, dividends, profitability & financials explained
Integer Holdings Corporation (ITGR) reported $1.84B in revenue for fiscal year 2025. This represents a 2224% increase from $79.2M in 1999.
Integer Holdings Corporation (ITGR) grew revenue by 7.6% over the past year. This is steady growth.
Yes, Integer Holdings Corporation (ITGR) is profitable, generating $128.4M in net income for fiscal year 2025 (5.6% net margin).
Integer Holdings Corporation (ITGR) has a return on equity (ROE) of 6.1%. This is below average, suggesting room for improvement.
Integer Holdings Corporation (ITGR) generated $112.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.